SCHEMBL7744779

SCHEMBL7744779

O=C(Nc1oc(-c2ccc(-c3ccccc3)cc2O)nc1C1=CC=CCC1=S)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 4/20 0.43
FLT1 P17948 1/20 0.43
FLT4 P35916 1/20 0.43
HDAC1 Q13547 4/20 0.39
HDAC2 Q92769 1/20 0.39
ALDH1A1 P00352 4/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
MAPT P10636 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
KDM4E B2RXH2 3/20 0.38
POLB P06746 3/20 0.38
GAA P10253 2/20 0.38
HPGD P15428 2/20 0.38
HSD17B10 Q99714 2/20 0.38
NPC1 O15118 1/20 0.37
TSHR P16473 1/20 0.37
RAB9A P51151 1/20 0.37
TP53 P04637 1/20 0.36
THRB P10828 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7979629 0.96 KDR (0.39) KDRFLT1FLT4HDAC1HDAC2
SCHEMBL7982878 0.93 MAPT (0.44) KDRFLT1FLT4HDAC2ALDH1A1
SCHEMBL7987348 0.93 KDR (0.44) KDRFLT1FLT4ALDH1A1MEN1
SCHEMBL7744196 0.91 KDR (0.54) KDRFLT1FLT4HDAC1ALDH1A1
SCHEMBL7744761 0.91 HPN (0.46) KDRFLT1FLT4HDAC2ALDH1A1
SCHEMBL7744056 0.85 HPGD (0.42) KDRFLT1FLT4HDAC1ALDH1A1
SCHEMBL7980768 0.84 KDR (0.45) KDRFLT1FLT4MEN1KMT2A
SCHEMBL7746598 0.82 KDR (0.58) KDRFLT1FLT4HDAC1HDAC2
SCHEMBL7986670 0.82 KDR (0.50) KDRFLT1FLT4SMN1; SMN2NPC1
SCHEMBL7746568 0.80 KDR (0.41) KDRFLT1FLT4HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed